Evidence map›Paper›PMID 38652155›Full record

ReviewJournal of experimental botany2025

Improving transformation and regeneration efficiency in medicinal plants: insights from other recalcitrant species.

Praveen Lakshman Bennur, Martin O'Brien, Shyama C Fernando, Monika S Doblin

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of experimental botany, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Engineering Agrobacterium for improved plant transformation.The Plant journal : for cell and molecular biology · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Praveen Lakshman BennurAustralian Research Council (ARC) Industrial Transformation Research Hub for Medicinal Agriculture, La Trobe Institute for Sustainable Agriculture and Food (LISAF), Department of Animal, Plant and Soil Sciences, La Trobe University, Victoria 3086, Australia.ORCID 0009-0008-4157-965X
Martin O'BrienAustralian Research Council (ARC) Industrial Transformation Research Hub for Medicinal Agriculture, La Trobe Institute for Sustainable Agriculture and Food (LISAF), Department of Animal, Plant and Soil Sciences, La Trobe University, Victoria 3086, Australia.ORCID 0009-0009-8072-6920
Shyama C FernandoAustralian Research Council (ARC) Industrial Transformation Research Hub for Medicinal Agriculture, La Trobe Institute for Sustainable Agriculture and Food (LISAF), Department of Animal, Plant and Soil Sciences, La Trobe University, Victoria 3086, Australia.ORCID 0000-0003-4208-484X
Monika S DoblinAustralian Research Council (ARC) Industrial Transformation Research Hub for Medicinal Agriculture, La Trobe Institute for Sustainable Agriculture and Food (LISAF), Department of Animal, Plant and Soil Sciences, La Trobe University, Victoria 3086, Australia.ORCID 0000-0002-8921-2725
Australian Research Council · AU

Funding

Australian Research Council to the Industrial Transformation Research Hub for Medicinal Agriculture IH180100006
6 · The paper itself

Abstract

Medicinal plants are integral to traditional medicine systems worldwide, being pivotal for human health. Harvesting plant material from natural environments, however, has led to species scarcity, prompting action to develop cultivation solutions that also aid conservation efforts. Biotechnological tools, specifically plant tissue culture and genetic transformation, offer solutions for sustainable, large-scale production and enhanced yield of valuable biomolecules. While these techniques are instrumental to the development of the medicinal plant industry, the challenge of inherent regeneration recalcitrance in some species to in vitro cultivation hampers these efforts. This review examines the strategies for overcoming recalcitrance in medicinal plants using a holistic approach, emphasizing the meticulous choice of explants (e.g. embryonic/meristematic tissues), plant growth regulators (e.g. synthetic cytokinins), and use of novel regeneration-enabling methods to deliver morphogenic genes (e.g. GRF/GIF chimeras and nanoparticles), which have been shown to contribute to overcoming recalcitrance barriers in agriculture crops. Furthermore, it highlights the benefit of cost-effective genomic technologies that enable precise genome editing and the value of integrating data-driven models to address genotype-specific challenges in medicinal plant research. These advances mark a progressive step towards a future where medicinal plant cultivation is not only more efficient and predictable but also inherently sustainable, ensuring the continued availability and exploitation of these important plants for current and future generations.

Indexed as

Plants, MedicinalRegenerationPlant Growth RegulatorsPlants, Genetically ModifiedTransformation, GeneticPlant Growth RegulatorsExplantsmedicinal plantsmorphogenic genesnanoparticlesplant growth regulatorsrecalcitranceregenerationtransformation

Identifiers

PMID38652155
PMCPMC11659184
OpenAlexW4395022882

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.